Cain Wettan Keeley M 4

What Happened

• Cain Wettan Keeley M, Executive Vice President, General Counsel, Legal & Compliance at Gilead Sciences, converted 589 restricted stock units (RSUs) into 589 shares on June 10, 2026. To satisfy tax withholding obligations, 283 of those shares were surrendered/withheld at a valuation of $121.48 per share, totaling $34,379. The remaining 306 shares were retained.
• This was not an open-market sale of shares for investment reasons but a routine tax-withholding event following RSU vesting/conversion.

Key Details

• Transaction date: 2026-06-10; Form 4 filed: 2026-06-11 (timely; within SEC 2-business-day window).
• Conversion: 589 RSUs converted to 589 common shares (transaction code M = exercise/conversion of derivative).
• Withholding: 283 shares disposed to cover taxes at $121.48/share, amounting to $34,379 (transaction code F = tax withholding).
• Shares owned after the transaction: not stated in this Form 4.
• Footnotes: F1 clarifies each RSU equals the right to one share; F2 notes the RSUs follow a four-year vesting schedule (25% after one year, then 6.25% quarterly).

Context

• This was effectively a vesting/conversion of RSUs with a tax-withholding surrender of shares (common and routine). It should not be read as a discretionary sale by the insider. For retail investors, purchases are generally more informative; this filing documents compensation vesting and related tax withholding rather than a market-directed buy or sell.